Supply breakdown
Shares as of Oct 22, 2026| Category | Shares | % | Value | Status |
|---|---|---|---|---|
| Circulating | 194.80M | 100.0% | $14.51B | Estimated |
| Free float | - | - | - | Unavailable |
| Insider-held, unrestricted | - | - | - | Unavailable |
| Locked team funds | - | - | - | Unavailable |
| Other restricted (unlisted classes only) | - | - | - | Unavailable |
| Total outstanding | 194.80M | 100.0% | $14.51B | Verified |
| Ownership views (overlap the categories above, never added) | ||||
| Institutional holdings (13F) | 193.65M | 99.4% | $14.42B | Estimated |
| Insider-held, all (Forms 3, 4, 5) | - | - | - | Unavailable |
Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: no class has more shares deducted than it has outstanding, and the review found no shares that may be counted twice: reconciles.
Valuation
- Traditional$14.51B
- Fully diluted-
- Circulating$14.51B
- Free float-
- Locked team value$0
- Other restricted value$0
Locked and restricted shares
Not reviewed yet.
Institutional holders
13F, quarter ended Jun 30, 2026| Holder | Shares | % of total |
|---|---|---|
| Jupiter Topco LLC | 14.11M | 7.24% |
| Kohlberg Kravis Roberts & Co. L.P. | 13.26M | 6.81% |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 10.74M | 5.51% |
| BlackRock, Inc. | 10.29M | 5.28% |
| VIKING GLOBAL INVESTORS LP | 9.95M | 5.11% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.90M | 4.05% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.66M | 3.93% |
| WELLINGTON MANAGEMENT GROUP LLP | 5.31M | 2.73% |
| TWO SIGMA INVESTMENTS, LP | 4.72M | 2.42% |
| Aisling Capital Management LP | 4.59M | 2.36% |
Sum of long share positions in Form 13F reports for the quarter. 13F covers managers with over $100M in US equities; some positions are reported by more than one filer.
Insiders
Forms 3, 4 and 5Form 4 aggregation pending
Share classes
| Class | Listing | Shares outstanding | As of |
|---|---|---|---|
| Common stock | BBIO on Nasdaq | 194,800,782 | Oct 22, 2026 |
Notes and sources
- BridgeBio Pharma, Inc. 10-Q for period ended 2026-09-30, Cover page (0001743881-26-000034)
- SEC public float (non-affiliates): $7.30B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.